Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Eye movement analysis during working memory tasks correlates with cognitive, clinical, and anatomical metrics in multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2026
Same author

Association of apolipoprotein E variants on Alzheimer's disease in Latin America: A systematic review and meta-analysis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Neurocognitive outcomes in older adults with multiple sclerosis: Evidence from a cross-sectional cohort.

Multiple sclerosis and related disorders·2025
Same author

Eye movements powered by artificial intelligence identify asymptomatic carriers of familial Alzheimer's disease.

Brain communications·2025
Same author

Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.

Multiple sclerosis and related disorders·2025
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

María Bárbara Eizaguirre1, Mario Parra2, Natalia Ciufia1

  • 1Ramos Mejía Hospital, Buenos Aires, Buenos Aires, Argentina.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

使用眼睛跟踪和人工智能的数字生物标志物ViewMind AtlasTM有效地检测出认知障碍 (CI),准确率为74%. 它的结果与传统测试相关,显示CI评估的临床有效性.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 眼科医生 眼科 眼科
  • 人工智能的人工智能

背景情况:

  • 认知障碍 (CI) 在神经退行性疾病和衰老中带来了挑战.
  • 传统的认知评估是昂贵的,难以获得的,耗时的.
  • ViewMind AtlasTM提供了一种新的,高效的数字生物标志物解决方案,使用眼睛跟踪和人工智能.

研究的目的:

  • 评估ViewMind AtlasTM用于检测CI.评估ViewMind AtlasTM用于检测CI.
  • 将ViewMind AtlasTM的结果与蒙特利尔认知评估 (MoCA) 和其他神经心理测试进行对比.
  • 评估ViewMind AtlasTM的临床有效性.

主要方法:

  • 一项对154名参与者 (年龄在45-95岁) 具有或没有认知投诉的横截面研究.
  • 使用头戴显示器 (HMD) 和眼睛跟踪传感器的ViewMind AtlasTM进行认知评估.
  • 在视觉任务中测量了冲击幅度,固定时间,再固定率和响应时间;与MoCA和神经心理学电池结果相比.

主要成果:

  • 在IC检测中,ViewMind AtlasTM实现了78%的灵敏度,70%的特异性和74%的平衡精度.
  • 在ViewMind指标和MoCA/神经心理测试得分之间发现了显著的相关性 (p < 0.05).
  • 这些发现证实了该工具识别认知障碍的能力.

结论:

  • 使用基于HMD的eye-tracking的ViewMind AtlasTM是CI检测的有效和高效工具.
  • 该系统与传统评估的强烈相关性支持其临床和研究实用性.
  • 这项技术在认知评估方面提供了有希望的进步.